Atlas Trials

Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS)

Clinical trial NCT03057990 · WITHDRAWN

Trial details

NCT number
NCT03057990
Sponsor
Montefiore Medical Center
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Myelodysplastic Syndromes
Start date
2019-09-11
Primary completion
2021-06-29
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.